Analysis of genetic copy number changes in cervical disease progression

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Policht, Frank A ^a   Song, Minghao ^a   Sitailo, Svetlana ^a   O'Hare, Anna ^a   Ashfaq, Raheela ^b   Muller, Carolyn Y ^c   Morrison, Larry E ^a   King, Walter ^a,d   Sokolova, Irina A ^a  

^a Abbott Molecular Inc   (United States)

^b CARIS LIFE SCIENCES   (United States)

^c UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^d GE HEALTHCARE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GRADING; CHROMOSOME 20Q; CHROMOSOME 3P; CHROMOSOME 3Q; CHROMOSOME 8Q; CHROMOSOME XP; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; HUMAN; HUMAN CELL; HUMAN TISSUE; SENSITIVITY AND SPECIFICITY; TUMOR GROWTH; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; CHROMOSOME 3; CHROMOSOME 8; CHROMOSOME ABERRATION; COPY NUMBER VARIATION; DISEASE COURSE; GENETICS; PATHOLOGY; PROGNOSIS; UTERINE CERVIX; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 8; DISEASE PROGRESSION; DNA COPY NUMBER VARIATIONS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; PROGNOSIS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS;

EID: 77955524629     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-432     Document Type: Article

References (36)

1. American Cancer Society What are the key statistics about Cervical Cancer?. American Cancer Society 2007, American Cancer Society.
2. Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, Cohen C. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002, 52(6):342-362. 10.3322/canjclin.52.6.342, 12469763.
3. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189(1):12-19. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F, 10451482.
4. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst 2000, 92(5):397-402. 10.1093/jnci/92.5.397, 10700419, The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group.
5. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni P, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006, 119(5):1095-1101. 10.1002/ijc.21955, 16586444.
6. Munger K, Baldwin A, Edwards KM, Hayakawa H, Nguyen CL, Owens M, Grace M, Huh K. Mechanisms of human papillomavirus-induced oncogenesis. J Virol 2004, 78(21):11451-11460. 10.1128/JVI.78.21.11451-11460.2004, 523272, 15479788.
7. Duensing S, Munger K. Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int J Cancer 2004, 109(2):157-162. 10.1002/ijc.11691, 14750163.
8. Dellas A, Torhorst J, Jiang F, Proffitt J, Schultheiss E, Holzgreve W, Sauter G, Mihatsch MJ, Moch H. Prognostic value of genomic alterations in invasive cervical squamous cell carcinoma of clinical stage IB detected by comparative genomic hybridization. Cancer Res 1999, 59(14):3475-3479.
9. Thein A, Trkova M, Fox M, Parrington J. The application of comparative genomic hybridization to previously karyotyped cervical cancer cell lines. Cancer Genet Cytogenet 2000, 116(1):59-65. 10.1016/S0165-4608(99)00108-9, 10616535.
10. Sugita M, Tanaka N, Davidson S, Sekiya S, Varella-Garcia M, West J, Drabkin HA, Gemmill RM. Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung. Cancer Genet Cytogenet 2000, 117(1):9-18. 10.1016/S0165-4608(99)00135-1, 10700859.
11. Mitra AB, Murty VV, Li RG, Pratap M, Luthra UK, Chaganti RS. Allelotype analysis of cervical carcinoma. Cancer Res 1994, 54(16):4481-4487.
12. Atkin NB, Baker MC. Nonrandom chromosome changes in carcinoma of the cervix uteri. I. Nine near-diploid tumors. Cancer Genet Cytogenet 1982, 7(3):209-222. 10.1016/0165-4608(82)90068-1, 7151039.
13. Choi YW, Bae SM, Kim YW, Lee HN, Park TC, Ro DY, Shin JC, Shin SJ, Seo JS, Ahn WS. Gene expression profiles in squamous cell cervical carcinoma using array-based comparative genomic hybridization analysis. Int J Gynecol Cancer 2007, 17(3):687-696. 10.1111/j.1525-1438.2007.00834.x, 17504382.
14. Kurtycz D, Nunez M, Arts T, Bauman C, Harris C, Inhorn S, Meisner L. Use of fluorescent in situ hybridization to detect aneuploidy in cervical dysplasia. Diagn Cytopathol 1996, 15(1):46-51. 10.1002/(SICI)1097-0339(199607)15:1<46::AID-DC9>3.0.CO;2-O, 8807251.
15. Aubele M, Zitzelsberger H, Schenck U, Walch A, Hofler H, Werner M. Distinct cytogenetic alterations in squamous intraepithelial lesions of the cervix revealed by laser-assisted microdissection and comparative genomic hybridization. Cancer 1998, 84(6):375-379. 10.1002/(SICI)1097-0142(19981225)84:6<375::AID-CNCR10>3.0.CO;2-1, 9915140.
16. Bulten J, Poddighe PJ, Robben JC, Gemmink JH, de Wilde PC, Hanselaar AG. Interphase cytogenetic analysis of cervical intraepithelial neoplasia. Am J Pathol 1998, 152(2):495-503. 1857973, 9466576.
17. Mark HF, Feldman D, Samy M, Sun C, Das S, Mark S, Lathrop J. Assessment of chromosome 8 copy number in cervical cancer by fluorescent in situ hybridization. Exp Mol Pathol 1999, 66(2):157-162. 10.1006/exmp.1999.2256, 10409444.
18. Kirchhoff M, Rose H, Petersen BL, Maahr J, Gerdes T, Philip J, Lundsteen C. Comparative genomic hybridization reveals non-random chromosomal aberrations in early preinvasive cervical lesions. Cancer Genet Cytogenet 2001, 129(1):47-51. 10.1016/S0165-4608(01)00424-1, 11520566.
19. Hidalgo A, Baudis M, Petersen I, Arreola H, Pina P, Vazquez-Ortiz G, Hernandez D, Gonzalez J, Lazos M, Lopez R, et al. Microarray comparative genomic hybridization detection of chromosomal imbalances in uterine cervix carcinoma. BMC Cancer 2005, 5:77. 10.1186/1471-2407-5-77, 1186020, 16004614.
20. Zhang A, Maner S, Betz R, Angstrom T, Stendahl U, Bergman F, Zetterberg A, Wallin KL. Genetic alterations in cervical carcinomas: frequent low-level amplifications of oncogenes are associated with human papillomavirus infection. Int J Cancer 2002, 101(5):427-433. 10.1002/ijc.10627, 12216070.
21. Harris CP, Lu XY, Narayan G, Singh B, Murty VV, Rao PH. Comprehensive molecular cytogenetic characterization of cervical cancer cell lines. Genes Chromosomes Cancer 2003, 36(3):233-241. 10.1002/gcc.10158, 12557223.
22. Wilting SM, Snijders PJ, Meijer GA, Ylstra B, van den Ijssel PR, Snijders AM, Albertson DG, Coffa J, Schouten JP, van de Wiel MA, et al. Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix. J Pathol 2006, 209(2):220-230. 10.1002/path.1966, 16538612.
23. Umayahara K, Numa F, Suehiro Y, Sakata A, Nawata S, Ogata H, Suminami Y, Sakamoto M, Sasaki K, Kato H. Comparative genomic hybridization detects genetic alterations during early stages of cervical cancer progression. Genes Chromosomes Cancer 2002, 33(1):98-102. 10.1002/gcc.1215, 11746992.
24. Heselmeyer K, Schrock E, du Manoir S, Blegen H, Shah K, Steinbeck R, Auer G, Ried T. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 1996, 93(1):479-484. 10.1073/pnas.93.1.479, 40262, 8552665.
25. Seppo A, Jalali GR, Babkowski R, Symiakaki H, Rodolakis A, Tafas T, Tsipouras P, Kilpatrick MW. Gain of 3q26: a genetic marker in low-grade squamous intraepithelial lesions (LSIL) of the uterine cervix. Gynecol Oncol 2009, 114(1):80-83. 10.1016/j.ygyno.2009.03.031, 19394683.
26. Caraway NP, Khanna A, Dawlett M, Guo M, Guo N, Lin E, Katz RL. Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma. Gynecol Oncol 2008, 110(1):37-42. 10.1016/j.ygyno.2008.01.040, 18433848.
27. Heselmeyer-Haddad K, Sommerfeld K, White NM, Chaudhri N, Morrison LE, Palanisamy N, Wang ZY, Auer G, Steinberg W, Ried T. Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer. Am J Pathol 2005, 166(4):1229-1238. 1602397, 15793301.
28. Tao X, Chon HS, Fu S, Kavanagh JJ, Hu W. Update on aurora kinase inhibitors in gynecologic malignancies. Recent Pat Anticancer Drug Discov 2008, 3(3):162-177. 10.2174/157489208786242322, 18991785.
29. Vader G, Lens SM. The Aurora kinase family in cell division and cancer. Biochim Biophys Acta 2008, 1786(1):60-72.
30. Sen S, Katayama H, Sasai K. Functional significance of Aurora kinase A in centrosome amplification and genomic instability. Adv Exp Med Biol 2008, 617:99-108. full_text, 18497034.
31. Schlecht NF, Platt RW, Duarte-Franco E, Costa MC, Sobrinho JP, Prado JC, Ferenczy A, Rohan TE, Villa LL, Franco EL. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst 2003, 95(17):1336-1343.
32. Melnikow J, Nuovo J, Willan AR, Chan BK, Howell LP. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 1998, 92(4 Pt 2):727-735. 10.1016/S0029-7844(98)00245-2, 9764690.
33. Holowaty P, Miller AB, Rohan T, To T. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 1999, 91(3):252-258. 10.1093/jnci/91.3.252, 10037103.
34. Alameda F, Espinet B, Corzo C, Munoz R, Bellosillo B, Lloveras B, Pijuan L, Gimeno J, Salido M, Sole F, et al. 3q26 (hTERC) gain studied by fluorescence in situ hybridization as a persistence-progression indicator in low-grade squamous intraepithelial lesion cases. Hum Pathol 2009, 40(10):1474-8. 10.1016/j.humpath.2009.03.013, 19540557.
35. Zhang Y, Wang X, Ma L, Wang Z, Hu L. Clinical significance of hTERC gene amplification detection by FISH in the screening of cervical lesions. J Huazhong Univ Sci Technolog Med Sci 2009, 29(3):368-371. 10.1007/s11596-009-0321-z, 19513624.
36. Wilting SM, de Wilde J, Meijer CJ, Berkhof J, Yi Y, van Wieringen WN, Braakhuis BJ, Meijer GA, Ylstra B, Snijders PJ, et al. Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer. Genes Chromosomes Cancer 2008, 47(10):890-905. 10.1002/gcc.20590, 2733213, 18618715.